Results 151 to 160 of about 3,125,063 (252)

Evolutionary mismatch between stomach capacity and modern diets: Implications for obesity and metabolic disease. [PDF]

Evol Med Public Health
Allouch M, Attieh P, Abdallah R, El Jamal K, Mohtar F, Zreika B, Kanso H, Ghadieh HE.   +7 more
europepmc   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Early-onset Presbyopes: Functional Impact and the Need for Clinical Recognition. [PDF]

Ophthalmic Physiol Opt
Prenat O, Puar M, Rosenfield M.
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

EDA Accommodation Validation 2024 - D1 - Demonstration Validation Plan

This document is the Demonstration Plan (DEMOP), for the EDA Accommodation Validation 2024 project and consists of the core document of the DEMOP, the Safety Plan and the Human Performance Plan.
Schmerwitz, Sven, Tump, Robert, de Gelder, Nico, Lieb, Joonas, Hesselink, Henk, Paz Goncalves Martins, Ana, Stolz, Maria   +6 more
core  

Defect-State Engineering in Doped CeO₂ for Oxygen Storage: Aliovalent Substitution, Co-Doping, and Pathway-Dependent Regulation. [PDF]

Molecules
Xu Y, Hou Q, Zhou Y, Ding Z.
europepmc   +1 more source

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird, Haley McQuown, Jihyun Park, Samuel J. Teener, Ian F. Webber‐Davis, Andrew D. Carter, Dae‐Gyu Jang, Eva L. Feldman, Stephen A. Goutman, Benjamin J. Murdock   +9 more
wiley   +1 more source

Manuscript: Redemption of Industry

, 1943
Unpublished manuscript, 13 pages; typed with ...
Tarbell, Ida M.
core  

Food Service Professionals' Experiences of Accommodating Dietary Requests and Texture Modification. [PDF]

Int J Lang Commun Disord
Hutchinson C, Howells S, Hutchison A, Rumbach A, Wishart L, Brown B, Packer RL.   +6 more
europepmc   +1 more source

Sex‐Stratified Association of Regional Dopamine Transporter Binding With Disease Progression in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the clinical relevance of dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) abnormalities in amyotrophic lateral sclerosis (ALS), with a prespecified focus on sex‐stratified associations with disease progression and short‐term prognosis.
Tomoya Kawazoe, Keizo Sugaya, Kentaro Hayashi, Keiko Hino, Yasuhiro Nakata, Kota Bokuda, Toshio Shimizu, Kazushi Takahashi   +7 more
wiley   +1 more source